1 |
Wang X, Li W, William M, Terada N, Alessi DR, Proud CG. 2001. Regulation of elongation factor 2 kinase by p90 (RSK1) and p70 kinase. EMBO J. 20:4370-4379.
DOI
ScienceOn
|
2 |
Li H, Choudhary SK, Milner DJ, Munir MJ, Kuisk IR, Capetanaki Y. 1994. Inhibition of desmin expression blocks myoblast fusion and interferes with the myogenic regulators MyoD and myogenin. J Cell Biol. 124:827-841.
DOI
ScienceOn
|
3 |
Weintraub H, Davis R, Tapscott S, Thayer M, Krause M, Benezra R, Blackwell T, Turner D, Rupp R, Hollenberg S. 1991. The myoD gene family: nodal point during specification of the muscle cell lineage. Science. 251:761- 766.
DOI
|
4 |
Wilson GM, Roberts EA, Deeley RG. 1997. Modulation of LDL receptor mRNA stability by phorbol esters in human liver cell culture models. J Lipid Res. 38:437-446.
|
5 |
Wright WE, Sassoon DA, Lin VK. 1989. Myogenin, a factor regulating myogenesis, has a domain homologous to myoD1. Cell. 56:607-617.
|
6 |
Woo JH, Kim HS. 2006. Phosphorylation of eukaryotic elongation factor 2 can be regulated by phosphoinositide 3-kinase in the early stages of myoblast differentiation. Mol Cells. 21:294-301.
|
7 |
Woo JH, Kim JH, Mook-Jung I, Kim HS. 2006. Lipid products of phosphoinositide 3-kinase abrogate genistein- induced fusion inhibition in myoblasts. Eur J Pharmacol. 529:84-94.
DOI
ScienceOn
|
8 |
Yano H, Nakanishi S, Kimura K, Hanai N, Saitoh Y, Fukui Y, Nonomura Y, Matsuda Y. 1993. Inhibition of histamine secretion by wortmannin through blockade of phosphatidylinositol 3-kinase in RBL-2H3 cells. J Biol Chem. 268:25846-25856.
|
9 |
Song A, Wang Q, Goebl MG, Harrington MA. 1998. Phosphorylation of nuclear MyoD is required for its rapid degradation. Mol Cell Biol. 18:4994-4998.
|
10 |
Shen WH, Boyle DW, Wisniowski P, Bade A, Liechty EA. 2005. Insulin and IGF-I stimulate the formation of the eukaryotic initiation factor 4F complex and protein synthesis in C2C12 myotubes independent of availability of external amino acids. J Endocrinol. 185:275-289.
DOI
ScienceOn
|
11 |
Sun H, Xu B, Sheveleva E, Chen QM. 2008. LY294002 inhibits glucocorticoid-induced COX-2 gene expression in cardiomyocytes through a phosphatidylinositol 3 kinase-independent mechanism. Toxicol Appl Pharmacol. 232:25-32.
|
12 |
Thayer MJ, Tapscott SJ, Davis RL, Wright WE, Lassar AB, Weintraub H. 1989. Positive autoregulation of the myogenic determination gene MyoDl. Cell. 58:241-248.
DOI
ScienceOn
|
13 |
Vanhaesebroeck B, Waterfield MD. 1999. Signaling by distinct classes of phosphoinositide 3-kinases. Exp Cell Res. 253:239-254.
DOI
ScienceOn
|
14 |
Lassar A, Munsterberg A. 1994. Wiring diagrams: regulatory circuits and the control of skeletal myogenesis. Curr Opin Cell Biol. 6:434-442.
|
15 |
Vin˜ als F, Ventura F. 2004. Myogenin protein stability is decreased by BMP-2 through a mechanism implicating Id1. J Biol Chem. 279:45766-45772.
DOI
ScienceOn
|
16 |
Wang L, Wang X, Proud CG. 2000. Activation of mRNA translation in rat cardiac myocytes by insulin involves multiple rapamycin-sensitive steps. Am J Physiol Heart Circ Physiol. 278(4):H1056-1068.
|
17 |
Knebel A, Morrice N, Cohen P. 2001. A novel method to identify protein kinase substrates: eEF2 kinase is phosphorylated and inhibited by SAPK4/p38delta. EMBO J. 20:4360-4369.
DOI
ScienceOn
|
18 |
Lopez-Carballo G, Moreno L, Masia S, Perez P, Barettino D. 2002. Activation of the phosphatidylinositol 3-kinase/Akt signaling pathway by retinoic acid is required for neural differentiation of SH-SY5Y human neuroblastoma cells. J Biol Chem. 277:25297-25304.
DOI
ScienceOn
|
19 |
McVean M, Xiao H, Isobe K, Pelling JC. 2000. Increase in wild-type p53 stability and transactivational activity by the chemopreventive agent apigenin in keratinocytes. Carcinogenesis. 21:633-639.
DOI
ScienceOn
|
20 |
Molkentin JD, Olson EN. 1996. Defining the regulatory networks for muscle development. Curr Opin Genet Dev. 6:445-453.
DOI
ScienceOn
|
21 |
Nakanishi S, Kakita S, Takahashi I, Kawahara K, Tsukuda E, Sano T, Yamada K, Yoshida M, Kase H, Matsuda Y. 1992. Wortmannin, a microbial product inhibitor of myosin light chain kinase. J Biol Chem. 267:2157-2163.
|
22 |
Olson EN. 1990. MyoD family: a paradigm for development? Genes Dev. 4:1454-1461.
DOI
ScienceOn
|
23 |
Perry RL, Rudnick MA. 2000. Molecular mechanisms regulating myogenic determination and differentiation. Front Biosci. 5:D750-767.
DOI
|
24 |
Sarker KP, Lee KY. 2004. L6 myoblasts differentiation is modulated by Cdk5 via the PI3K-AKT-p70S6K signaling pathway. Oncogene. 23:6064-6070.
DOI
ScienceOn
|
25 |
Proud CG. 2004. Ras, PI3-kinase and mTOR signaling in cardiac hypertrophy. Cardiovasc Res. 63:403-413.
DOI
ScienceOn
|
26 |
Ruvinsky I, Meyuhas O. 2006. Ribosomal protein S6 phosphorylation: from protein synthesis to cell size. Trends Biochem Sci. 31:342-348.
DOI
ScienceOn
|
27 |
Ryazonov AG, Davydova EK. 1989. Mechanism of elongation factor 2 (EF-2) inactivation upon phosphorylation. Phosphorylated EF-2 is unable to calalyze translocation. FEBS Lett 251:187-190.
DOI
ScienceOn
|
28 |
Herbert GB, Shi B, Gartenhaus RB. 2001. Expression and stabilization of the MCT-1 protein by DNA damaging agents. Oncogene. 20:6777-6783.
DOI
ScienceOn
|
29 |
Jeon YJ, Kim HS, Kim HS, Kang MS, Chung CH, Ha DB. 1994. The 100-kDa protein, whose phosphorylation precedes the fusion of chick embryonic myoblasts, is the eukaryotic elongation factor-2. Biochem Biophys Res Commun. 198:132-137.
DOI
ScienceOn
|
30 |
Jiang BH, Zheng JZ, Vogt PK. 1998. An essential role of phosphatidylinositol 3-kinase in myogenic differentiation. Proc Natl Acad Sci USA. 95:14179-14183.
DOI
ScienceOn
|
31 |
Kaliman P, Vinals F, Testar X, Palacin M, Zorzano A. 1996. Phosphatidylinositol 3-kinase inhibitors block differentiation of skeletal muscle cells. J Biol Chem. 271:19146- 19151.
DOI
ScienceOn
|
32 |
Giorgino F, Pedrini MT, Matera L, Smith RJ. 1997. Specific increase in p85alpha expression in response to dexamethasone is associated with inhibition of insulinlike growth factor-I stimulated phosphatidylinositol 3- kinase activity in cultured muscle cells. J Biol Chem. 272:7455-7463.
DOI
ScienceOn
|
33 |
Emerson CP. 1990. Myogenesis and developmental control genes. Curr Opin Cell Biol. 2:1065-1075.
DOI
ScienceOn
|
34 |
Figueroa A, Cuadrado A, Fan J, Atasoy U, Muscat GE, Munoz-Canoves P, Gorospe M, Munoz A. 2003. Role of HuR in skeletal myogenesis through coordinate regulation of muscle differentiation genes. Mol Cell Biol. 23:4991-5004.
DOI
ScienceOn
|
35 |
Franch HA, Sooparb S, Du J. 2001. A mechanism regulating proteolysis of specific proteins during renal tubular cell growth. J Biol Chem. 276:19126-19131.
DOI
ScienceOn
|
36 |
Franch HA, Wang X, Sooparb S, Brown NS, Du J. 2002. Phosphatidylinositol 3-kinase activity is required for epidermal growth factor to suppress proteolysis. J Am Soc Nephrol 13:903-909.
|
37 |
Gharbi SI, Zvelebil MJ, Shuttleworth SJ, Hancox T, Saghir N, Timms JF, Waterfield MD. 2007. Exploring the specificity of the PI3K family inhibitor LY294002. Biochem J. 404:15-21.
DOI
ScienceOn
|
38 |
Hay N, Sonenberg N. 2004. Upstream and downstream of mTOR. Genes Dev. 18:1926-1945.
DOI
ScienceOn
|
39 |
Alvarez B, Garrido E, Garcia-Sanz JA, Carrera AC. 2003. Phosphoinositide 3-kinase activation regulates cell division time by coordinated control of cell mass and cell cycle progression rate. J Biol Chem. 278:26466-26473.
DOI
ScienceOn
|
40 |
Arnold HH, Braun T. 1996. Targeted inactivation of myogenic factor genes reveals their role during mouse myogenesis: a review. Int J Dev Biol. 40:345-363.
|
41 |
Benezra R, Davis RL, Lockshon D, Turner DL, Weintraub H. 1990. The protein Id: a negative regulator of helixloop- helix DNA binding proteins. Cell. 61:49-59.
DOI
ScienceOn
|
42 |
Edmondson DG, Brennan TJ, Olson EN. 1991. Mitogenic repression of myogenin autoregulation. J Biol Chem. 266:21343-21346.
|
43 |
Brand-Saberi B, Christ B. 1999. Genetic and epigenetic control of muscle development in vertebrates. Cell Tissue Res. 296:199-212.
DOI
ScienceOn
|
44 |
Browne GJ, Proud CG. 2002. Regulation of peptidechain elongation in mammalian cells. Eur J Biochem. 269:5360-5368.
DOI
ScienceOn
|
45 |
Edmondson DG, Olson EN. 1989. A gene with homology to the myc similarity region of MyoD1 is expressed during myogenesis and is sufficient to activate the muscle differentiation program. Genes Dev. 3:628-640.
DOI
ScienceOn
|
46 |
Edwards DR, Mahadevan LC. 1992. Protein synthesis inhibitors differentially superinduce c-fos and c-jun by three distinct mechanisms: lack of evidence for labile repressors. EMBO J. 11:2415-2424.
|